Logo image of SVS.MI

SVAS BIOSANA SPA (SVS.MI) Stock Fundamental Analysis

BIT:SVS - Euronext Milan - IT0005469264 - Common Stock - Currency: EUR

7.94  -0.24 (-2.93%)

Fundamental Rating

6

Overall SVS gets a fundamental rating of 6 out of 10. We evaluated SVS against 57 industry peers in the Health Care Equipment & Supplies industry. SVS has an average financial health and profitability rating. SVS is growing strongly while it also seems undervalued. This is an interesting combination


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SVS had positive earnings in the past year.
SVS had a positive operating cash flow in the past year.
SVS had positive earnings in each of the past 5 years.
Each year in the past 5 years SVS had a positive operating cash flow.
SVS.MI Yearly Net Income VS EBIT VS OCF VS FCFSVS.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M 8M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.44%, SVS is in line with its industry, outperforming 53.33% of the companies in the same industry.
SVS has a Return On Equity of 9.25%. This is in the better half of the industry: SVS outperforms 70.00% of its industry peers.
With a decent Return On Invested Capital value of 7.57%, SVS is doing good in the industry, outperforming 73.33% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SVS is in line with the industry average of 8.08%.
The last Return On Invested Capital (7.57%) for SVS is above the 3 year average (6.10%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROIC 7.57%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
SVS.MI Yearly ROA, ROE, ROICSVS.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

The Profit Margin of SVS (4.49%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of SVS has grown nicely.
Looking at the Operating Margin, with a value of 8.07%, SVS is in line with its industry, outperforming 51.67% of the companies in the same industry.
SVS's Operating Margin has improved in the last couple of years.
The Gross Margin of SVS (25.79%) is worse than 83.33% of its industry peers.
SVS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
SVS.MI Yearly Profit, Operating, Gross MarginsSVS.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SVS is still creating some value.
Compared to 1 year ago, SVS has less shares outstanding
Compared to 5 years ago, SVS has less shares outstanding
SVS has a worse debt/assets ratio than last year.
SVS.MI Yearly Shares OutstandingSVS.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
SVS.MI Yearly Total Debt VS Total AssetsSVS.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 1.86 indicates that SVS is not a great score, but indicates only limited risk for bankruptcy at the moment.
SVS has a Altman-Z score of 1.86. This is comparable to the rest of the industry: SVS outperforms 48.33% of its industry peers.
SVS has a debt to FCF ratio of 1707.47. This is a negative value and a sign of low solvency as SVS would need 1707.47 years to pay back of all of its debts.
SVS's Debt to FCF ratio of 1707.47 is in line compared to the rest of the industry. SVS outperforms 46.67% of its industry peers.
SVS has a Debt/Equity ratio of 0.64. This is a neutral value indicating SVS is somewhat dependend on debt financing.
SVS's Debt to Equity ratio of 0.64 is on the low side compared to the rest of the industry. SVS is outperformed by 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Altman-Z 1.86
ROIC/WACC1.1
WACC6.89%
SVS.MI Yearly LT Debt VS Equity VS FCFSVS.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 1.96 indicates that SVS should not have too much problems paying its short term obligations.
SVS has a Current ratio (1.96) which is in line with its industry peers.
A Quick Ratio of 1.42 indicates that SVS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.42, SVS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.42
SVS.MI Yearly Current Assets VS Current LiabilitesSVS.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.52% over the past year.
Measured over the past years, SVS shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.81% on average per year.
The Revenue has grown by 12.19% in the past year. This is quite good.
Measured over the past years, SVS shows a quite strong growth in Revenue. The Revenue has been growing by 11.34% on average per year.
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%

3.2 Future

Based on estimates for the next years, SVS will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.90% on average per year.
SVS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.45% yearly.
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SVS.MI Yearly Revenue VS EstimatesSVS.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
SVS.MI Yearly EPS VS EstimatesSVS.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0.5 1

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.78, the valuation of SVS can be described as very cheap.
Based on the Price/Earnings ratio, SVS is valued cheaply inside the industry as 98.33% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.29. SVS is valued rather cheaply when compared to this.
SVS is valuated cheaply with a Price/Forward Earnings ratio of 6.05.
Based on the Price/Forward Earnings ratio, SVS is valued cheaper than 96.67% of the companies in the same industry.
SVS is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.78
Fwd PE 6.05
SVS.MI Price Earnings VS Forward Price EarningsSVS.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SVS is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SVS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 1195.27
EV/EBITDA 3.54
SVS.MI Per share dataSVS.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SVS has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SVS's earnings are expected to grow with 16.90% in the coming years.
PEG (NY)0.38
PEG (5Y)0.34
EPS Next 2Y22.24%
EPS Next 3Y16.9%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.16%, SVS has a reasonable but not impressive dividend return.
SVS's Dividend Yield is rather good when compared to the industry average which is at 2.07. SVS pays more dividend than 90.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, SVS pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.16%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y22.24%
EPS Next 3Y16.9%
SVS.MI Yearly Income VS Free CF VS DividendSVS.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 0 2M -2M 4M

SVAS BIOSANA SPA

BIT:SVS (6/19/2025, 7:00:00 PM)

7.94

-0.24 (-2.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.77%
Inst Owner ChangeN/A
Ins Owners64.79%
Ins Owner ChangeN/A
Market Cap44.46M
Analysts80
Price Target13.87 (74.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.16%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.68%
PT rev (3m)9.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.87%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.04%
Valuation
Industry RankSector Rank
PE 7.78
Fwd PE 6.05
P/S 0.37
P/FCF 1195.27
P/OCF 7.26
P/B 0.75
P/tB 0.94
EV/EBITDA 3.54
EPS(TTM)1.02
EY12.85%
EPS(NY)1.31
Fwd EY16.54%
FCF(TTM)0.01
FCFY0.08%
OCF(TTM)1.09
OCFY13.77%
SpS21.7
BVpS10.52
TBVpS8.44
PEG (NY)0.38
PEG (5Y)0.34
Profitability
Industry RankSector Rank
ROA 3.44%
ROE 9.25%
ROCE 9.95%
ROIC 7.57%
ROICexc 11.41%
ROICexgc 13.88%
OM 8.07%
PM (TTM) 4.49%
GM 25.79%
FCFM 0.03%
ROA(3y)2.62%
ROA(5y)2.53%
ROE(3y)7.15%
ROE(5y)8.28%
ROIC(3y)6.1%
ROIC(5y)6.5%
ROICexc(3y)9.61%
ROICexc(5y)8.9%
ROICexgc(3y)11.85%
ROICexgc(5y)10.85%
ROCE(3y)8.02%
ROCE(5y)10.69%
ROICexcg growth 3Y15.29%
ROICexcg growth 5Y7.17%
ROICexc growth 3Y14.84%
ROICexc growth 5Y6.65%
OM growth 3Y4.61%
OM growth 5Y3.21%
PM growth 3Y9.42%
PM growth 5Y9.36%
GM growth 3Y-7.01%
GM growth 5Y-4.71%
F-Score8
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 1707.47
Debt/EBITDA 2.51
Cap/Depr 118.33%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 40.95%
Profit Quality 0.68%
Current Ratio 1.96
Quick Ratio 1.42
Altman-Z 1.86
F-Score8
WACC6.89%
ROIC/WACC1.1
Cap/Depr(3y)116.12%
Cap/Depr(5y)115.75%
Cap/Sales(3y)5.74%
Cap/Sales(5y)5.77%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.52%
EPS 3Y28.6%
EPS 5Y22.81%
EPS Q2Q%15.52%
EPS Next Y20.69%
EPS Next 2Y22.24%
EPS Next 3Y16.9%
EPS Next 5YN/A
Revenue 1Y (TTM)12.19%
Revenue growth 3Y15.87%
Revenue growth 5Y11.34%
Sales Q2Q%5.91%
Revenue Next Year5.8%
Revenue Next 2Y10.19%
Revenue Next 3Y8.45%
Revenue Next 5YN/A
EBIT growth 1Y24.73%
EBIT growth 3Y21.21%
EBIT growth 5Y14.92%
EBIT Next Year83.74%
EBIT Next 3Y31.21%
EBIT Next 5Y24.44%
FCF growth 1Y100.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y212.56%
OCF growth 3Y9.06%
OCF growth 5Y6.2%